Salt intake, stroke, and cardiovascular disease: Meta-analysis of prospective studies

BMJ (Online)

Volumn 339, Issue 7733, 2009, Pages 1296-

  Strazzullo, Pasquale ^a   D'Elia, Lanfranco ^a   Kandala, Ngianga Bakwin ^b   Cappuccio, Francesco P ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CINAHL; CLINICAL ASSESSMENT; CLINICAL TRIAL; COCHRANE LIBRARY; COHORT ANALYSIS; EFFECT SIZE; FOLLOW UP; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCINFO; RISK FACTOR; SALT INTAKE; SENSITIVITY ANALYSIS; SODIUM INTAKE; STROKE; SYSTEMATIC REVIEW;

ADULT; AGED; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SODIUM, DIETARY; STROKE;

EID: 71749104303     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b4567     Document Type: Article

References (45)

1. He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens 2009;23:363-384
2. World Health Organization. Reducing salt intake in populations: report of a WHO forum and technical meeting. WHO, 2007:1-60.
3. He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens 2002;16:761-770
4. He FJ, MacGregor GA. How far should salt intake be reduced? Hypertension 2003;42:1093-1099
5. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 1999;354:1896-1900
6. Alderman MH, Madhavan S, Cohen H, Sealey JE, Laragh JH. Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension 1995;25:1144-1152
7. Alderman MH, Sealey JE, Cohen H, Madhavan S and Laragh JH. Urinary sodium excretion and myocardial infarction in hypertensive patients: a prospective cohort study. Am J Clin Nutr 1997;65(suppl):682-6S.
8. Alderman MH, Cohen H, Madhavan S. Dietary sodium intake and mortality: the national health and nutrition examination survey (NHANES I). Lancet 1998;351:781-785 (Pubitemid 28112339)
9. He J, Ogden LG, Vupputuri S, Bazzano LA, Loria C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA 1999;282:2027-2034
10. Kagan A, Popper JS, Rhoads GG, Yano K. Dietary and other risk factors for stroke in Hawaiian Japanese men. Stroke 1985;16:390-396 (Pubitemid 15034418)
11. Hu HH, Sheng WY, Chu FL, Lan CF, Chiang BN. Incidence of stroke in Taiwan. Stroke 1992;23:1237-1241
12. Tunstall-Pedoe H, Woodward M, Tavendale R, A'Brook R, McCluskey MK. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish heart health study: cohort study. BMJ 1997;315:722-729 (Pubitemid 27405828)
13. Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, Pietinen, P, et al. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 2001;357:848-851 (Pubitemid 32239370)
14. Nagata C, Takatsuka N, Shimizu N, Shimizu H. Sodium intake and risk of death from stroke in Japanese men and women. Stroke 2004;35:1543-1547 (Pubitemid 38823620)
15. Cohen HW, Hailpern SM, Fang J, Alderman MH. Sodium intake and mortality in the NHANES II follow-up study. Am J Med 2006;119:275 e7-14.
16. Geleijnse JM, Witteman JC, Stijnen T, Kloos MW, Hofman A, Grobbee DE. Sodium and potassium intake and risk of cardiovascular events and all-cause mortality: the Rotterdam study. Eur J Epidemiol 2007;22:763-770 (Pubitemid 350105371)
17. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007;33:885-888 (Pubitemid 46724330)
18. Larsson SC, Virtanen MJ, Mars M, Mannisto S, Pietinen P, Albanes D, et al. Magnesium, calcium, potassium, and sodium intakes and risk of stroke in male smokers. Arch Intern Med 2008;168:459-465 (Pubitemid 351547209)
19. Umesawa M, Iso H, Date C, Yamamoto A, Toyoshima H, Watanabe Y, et al. Relations between dietary sodium and potassium intakes and mortality from cardiovascular disease: the Japan collaborative cohort study for evaluation of cancer risks. Am J Clin Nutr 2008;88:195-202. (Pubitemid 351988704)
20. Cohen HW, Hailpern SM, Alderman MH. Sodium intake and mortality follow-up in the third national health and nutrition examination survey (NHANES III). J Gen Intern Med 2008;23:1297-1302
21. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998;52:377-384 (Pubitemid 28438523)
22. Dersimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188
23. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560
24. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634 (Pubitemid 27387172)
25. Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR. Empirical assessment of effect of publication bias on meta-analyses. BMJ 2000;320:1574-1577 (Pubitemid 30336090)
26. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KG. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol 2006;6:50. (Pubitemid 44662384)
27. World Health Organization. The world health report 2002 - reducing risks promoting healthy life. WHO, 2002.
28. Scientific Advisory Committee on Nutrition. Salt and health. Stationery Office, 2003:1-134.
29. World Health Organization. Reducing salt intake in populations. Report of a WHO forum and technical meeting. WHO, 2007:1-60.
30. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913 (Pubitemid 35472129)
31. Karppanen H, Mervaala E. Sodium intake and mortality. Lancet 1998;351:1509.
32. Kupari M, Koskinen P, Virolainen J. Correlates of left ventricular mass in a population sample aged 36 to 37 years. Focus on lifestyle and salt intake. Circulation 1994;89:1041-1050
33. Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD. Dietary salt intake. A determinant of cardiac involvement in essential hypertension. Circulation 1988;78:951-956
34. Du Calair G, Ribstein J, Daures JP, Mimran A. Sodium and left ventricular mass in untreated hypertensive and normotensive subjects. Am J Physiol 1992;263:H177-81.
35. Avolio AP, Clyde KM, Beard TC, Cooke HM, Ho KK,O'Rourke MF. Improved arterial distensibility in normotensive subjects on a low salt diet. Arteriosclerosis 1986;6:166-169
36. Du Calair G, Ribstein J, Mimran A. Dietary sodium and target organ damage in essential hypertension. Am J Hypertens 2002;15:222-229 (Pubitemid 34226186)
37. Verhave JC, Hillege HL, Burgerhof JG, Janssen WM, Gansevoort RT, Navis GJ, et al. Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med 2004;256:324-330
38. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. Obes Res 1998;(suppl 2):51-209S.
39. Strazzullo P, Barba G, Cappuccio FP, Siani A, Trevisan M, Farinaro E, et al. Altered renal sodium handling in men with abdominal adiposity and insulin resistance: a link to hypertension. J Hypertens 2001;19:2157-2164 (Pubitemid 33135236)
40. World Health Organization. The world health report 2004 - changing history. WHO, 2004.
41. Selmer RM, Kristiansen IS, Haglerod A, Graff-Iversen S, Larson HK, Meyer HE, et al. Cost and health consequences of reducing the population intake of salt. J Epidemiol Community Health 2000;54:697-702. (Pubitemid 30639403)
42. Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 2003;361:717-725 (Pubitemid 36293625)
43. Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 2007;370:2044-2053 (Pubitemid 50007973)
44. Godlee F. The food industry fights for salt. BMJ 1996;312:1239-1240
45. Cappuccio FP. Salt and cardiovascular disease. BMJ 2007;334:859-860